Skip to main content

Breadcrumb

  1. Home

PDGFB Rearrangement (22q13)

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:54
  • Read more about PDGFB Rearrangement (22q13)

MYC Amplification for Angiosarcoma

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:54
  • Read more about MYC Amplification for Angiosarcoma

CD4/CD8 Ratio for BAL

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:54
  • Read more about CD4/CD8 Ratio for BAL

Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:54
  • Read more about Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma

NRAS Mutation Analysis by PCR

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:54
  • Read more about NRAS Mutation Analysis by PCR

OCT4

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:54
  • Read more about OCT4

OCT2

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:54
  • Read more about OCT2

Mismatch Repair (MMR) IHC Panel

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:54
  • Read more about Mismatch Repair (MMR) IHC Panel

MYC/IgH/CEN8 t(8;14)

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:54
  • Read more about MYC/IgH/CEN8 t(8;14)

AML Add-On Flow Panel

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:54
  • Read more about AML Add-On Flow Panel

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • …
  • Next page Next
  • Last page Last
Subscribe to